Phreesia (NYSE:PHR) Price Target Raised to $30.00 at KeyCorp

Phreesia (NYSE:PHR) had its target price boosted by KeyCorp from $28.00 to $30.00 in a research report sent to investors on Wednesday morning,Benzinga reports. The brokerage currently has an overweight rating on the stock.

PHR has been the subject of a number of other reports. Robert W. Baird decreased their price target on shares of Phreesia from $34.00 to $30.00 and set an “outperform” rating for the company in a report on Wednesday, December 11th. Needham & Company LLC reaffirmed a “buy” rating and issued a $29.00 target price on shares of Phreesia in a report on Tuesday, December 10th. Royal Bank of Canada raised Phreesia from a “sector perform” rating to an “outperform” rating and lifted their price target for the stock from $24.00 to $32.00 in a research report on Wednesday. Truist Financial increased their price objective on Phreesia from $31.00 to $34.00 and gave the company a “buy” rating in a research report on Wednesday, December 11th. Finally, JMP Securities reaffirmed a “market outperform” rating and set a $30.00 target price on shares of Phreesia in a research report on Tuesday, December 10th. Eleven equities research analysts have rated the stock with a buy rating, According to MarketBeat.com, the stock presently has an average rating of “Buy” and an average price target of $30.64.

Phreesia Stock Performance

PHR opened at $28.42 on Wednesday. The company has a debt-to-equity ratio of 0.04, a quick ratio of 1.77 and a current ratio of 1.74. The company has a market cap of $1.65 billion, a PE ratio of -19.33 and a beta of 0.94. The stock has a 50-day moving average of $22.50 and a 200-day moving average of $22.53. Phreesia has a 52-week low of $17.07 and a 52-week high of $29.16.

Phreesia (NYSE:PHR) last announced its quarterly earnings results on Monday, December 9th. The company reported ($0.25) EPS for the quarter, beating the consensus estimate of ($0.29) by $0.04. Phreesia had a negative return on equity of 32.78% and a negative net margin of 20.43%. The company had revenue of $106.80 million for the quarter, compared to the consensus estimate of $106.33 million. During the same quarter last year, the company posted ($0.58) earnings per share. The company’s revenue for the quarter was up 16.6% compared to the same quarter last year. As a group, equities research analysts forecast that Phreesia will post -1.16 earnings per share for the current fiscal year.

Insider Transactions at Phreesia

In other news, General Counsel Allison C. Hoffman sold 3,982 shares of the company’s stock in a transaction dated Monday, January 6th. The shares were sold at an average price of $26.61, for a total value of $105,961.02. Following the sale, the general counsel now owns 159,137 shares of the company’s stock, valued at approximately $4,234,635.57. This represents a 2.44 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Also, SVP David Linetsky sold 2,011 shares of Phreesia stock in a transaction dated Tuesday, October 15th. The shares were sold at an average price of $21.03, for a total transaction of $42,291.33. Following the transaction, the senior vice president now directly owns 201,307 shares of the company’s stock, valued at $4,233,486.21. This represents a 0.99 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last three months, insiders sold 101,703 shares of company stock valued at $2,343,541. Company insiders own 5.80% of the company’s stock.

Hedge Funds Weigh In On Phreesia

Several institutional investors have recently bought and sold shares of the business. International Assets Investment Management LLC lifted its position in shares of Phreesia by 2,179.7% during the third quarter. International Assets Investment Management LLC now owns 1,459 shares of the company’s stock worth $33,000 after purchasing an additional 1,395 shares in the last quarter. Lombard Odier Asset Management USA Corp acquired a new position in Phreesia during the 2nd quarter worth $202,000. Point72 DIFC Ltd acquired a new position in Phreesia during the 2nd quarter worth $209,000. XTX Topco Ltd bought a new position in Phreesia in the 3rd quarter valued at $247,000. Finally, Hsbc Holdings PLC acquired a new stake in shares of Phreesia in the 2nd quarter valued at $301,000. Institutional investors own 92.10% of the company’s stock.

About Phreesia

Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.